Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs

被引:4
|
作者
Kaminski, R
Przywara, B
Gasior, M
Kleinrok, Z
Czuczwar, SJ
机构
[1] Med Univ Sch, Dept Pharmacol & Toxicol, PL-20090 Lublin, Poland
[2] Inst Rural Med, Dept Clin Toxicol, Lublin, Poland
关键词
5-fluoroindole-2-carboxylic acid; antiepileptics; carbamazepine; diphenylhydantoin; phenobarbital; valproate; seizures;
D O I
10.1007/s007020050043
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
5-Fluoroindole-2-carboxylic acid, an antagonist of the glycine site within the NMDA receptor complex, administered intraperitoneally in doses of 150 and 200mg/kg, 120min before electroconvulsions, significantly raised the convulsive threshold from 6.8 to 7.9 and 8.3mA, respectively. At lower doses, it did not influence the threshold. However, lethality was observed 24h after administration of the threshold-elevating doses of this glycine site antagonist. 5-Fluoroindole-2-carboxylic acid (100mg/kg), applied together with carbamazepine, valproate or phenobarbital, significantly reduced their ED50 values against maximal electroshock - from 13.9 to 7.5 mg/kg, from 291 to 242 mg/kg, and from 18.6 to 11.1 mg/kg, respectively. At the dose of 50 mg/kg, it also potentiated the protective activity of carbamazepine. However, 5-fluoroindole-2-carboxylic acid, up to 100mg/kg, did not affect the anticonvulsive activity of diphenylhydantoin. When applied at doses equal to their ED50 values against maximal electroshock-induced convulsions, carbamazepine (13.9mg/kg), phenobarbital (18.6 mg/kg) and valproate (291mg/kg) did not affect the motor performance of mice in the chimney test. 5-Fluoroindole-2-carboxylic acid (100mg/ kg) produced a significant motor impairment, at 50 mg/kg it did not affect the motor performance. The combined treatment of 5-fluoroindole-2-carboxylic acid (100 mg/kg) with carbamazepine, phenobarbital or valproate, providing a 50% protection against maximal electroshock, resulted in motor impairment. Only the combination of 5-fluoroindole-2-carboxylic acid (50 mg/kg) with carbamazepine (8.6mg/kg) did not significantly influence this parameter. Almost all of the antiepileptic drugs studied, when administered at doses equal to their ED50 values against maximal electroshock, did not influence retention in the passive avoidance task, which is a measure of long-term memory. Only valproate (291mg/kg) worsened long-term memory. The combined treatment of 5-fluoroindole-2-carboxylic acid (100mg/kg) with carbamazepine or phenobarbital, providing a 50% protection against maximal electroshock, did not affect the retention. The combination of 5-fluoroindole-2-carboxylic acid (100 mg/kg) with valproate (242 mg/kg) caused a significant impairment of long-term memory and mortality of 50% of animals 24h following the administration. The results suggest that the blockade of the strychnine-insensitive glycine site may lead to an enhancement of the protective activity of some conventional antiepileptic drugs, which is associated with pronounced side-effects and lethality in some cases.
引用
收藏
页码:133 / 146
页数:14
相关论文
共 35 条
  • [1] Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs
    R. Kamiński
    B. Przywara
    M. Gasior
    Z. Kleinrok
    S. J. Czuczwar
    Journal of Neural Transmission, 1998, 105 : 133 - 146
  • [2] NMDA receptor glycine site antagonist (indole-2-carboxylic acid) enhances the anticonvulsive activity of antiepileptic drugs
    Kaminski, R
    Wolinska, E
    Gasior, M
    Kleinrok, Z
    Czuczwar, SJ
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 1998, 22 (03) : 137 - 145
  • [3] Blockade of the NMDA receptor-associated glycine site and the protective activity of antiepileptic drugs in electroshock-induced seizures in mice
    Kaminski, R
    Przywara, B
    Gasior, M
    Kleinrok, Z
    Czuczwar, SJ
    POLISH JOURNAL OF PHARMACOLOGY, 1997, 49 (01): : 70 - 71
  • [4] Influence of the antagonist of the glycine site of NMDA receptors, MRZ 2/576, on the anticonvulsant activity of conventional antiepileptic drugs in mice
    Makarska-Bialek, K
    Kaminski, RM
    Czuczwar, SJ
    PHARMACOLOGICAL REPORTS, 2005, 57 (04) : 458 - 466
  • [5] LY 300164, a novel non-NMDA receptor antagonist, potentiates the anticonvulsive activity of antiepileptic drugs
    Czuczwar, SJ
    Kaminski, R
    Gasior, M
    Kozicka, M
    Zawadzki, A
    Kleinrok, Z
    4TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 1997, : 35 - 39
  • [7] ANTICONVULSANT ACTIVITY OF ANTAGONISTS AND PARTIAL AGONISTS FOR THE NMDA RECEPTOR-ASSOCIATED GLYCINE SITE IN THE KINDLING MODEL OF EPILEPSY
    RUNDFELDT, C
    WLAZ, P
    LOSCHER, W
    BRAIN RESEARCH, 1994, 653 (1-2) : 125 - 130
  • [8] 5,7-dichlorokynurenic acid hydrate, an antagonist for the glycine binding site on the NMDA receptor
    Kubicki, M
    Bassyouni, HAR
    Codding, PW
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1997, 53 : 739 - 742
  • [9] ACTIVITY OF 5,7-DICHLOROKYNURENIC ACID, A POTENT ANTAGONIST AT THE N-METHYL-D-ASPARTATE RECEPTOR-ASSOCIATED GLYCINE BINDING-SITE
    BARON, BM
    HARRISON, BL
    MILLER, FP
    MCDONALD, IA
    SALITURO, FG
    SCHMIDT, CJ
    SORENSEN, SM
    WHITE, HS
    PALFREYMAN, MG
    MOLECULAR PHARMACOLOGY, 1990, 38 (04) : 554 - 561
  • [10] Effect of MPEP, a selective mGlur5 antagonist, on the antielectroshock activity of conventional antiepileptic drugs
    Zadrozniak, M
    Sekowski, A
    Czuczwar, SJ
    Borowicz, KK
    POLISH JOURNAL OF PHARMACOLOGY, 2004, 56 (05): : 595 - 598